Skip to main content

Barwon Health / Research

(03) 4215 0000

Cardiothoracic Surgery - A/Prof Cheng-Hon Yap

Background

  • Cardiothoracic Surgeon, University Hospital Geelong, Victoria, Australia.
  • Visiting Cardiothoracic Surgeon and Clinical Lead for Cardiac Services, St John of God Geelong Hospital, Victoria, Australia.
  • Visiting Cardiothoracic Surgeon, Grampians Health Ballarat, Victoria, Australia.
  • Affiliate Associate Professor, School of Medicine, Deakin University, Victoria, Australia.
  • Adjunct Senior Research Fellow, Department of Epidemiology and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Victoria, Australia.

Research FocusCH Yap about me

  • Victorian Lung Cancer Registry, St John of God Geelong Hospital Principal Investigator.
  • The STABLE-MATES Trial, University Hospital Geelong Principal Investigator. A Randomized Phase III Study of Sublobar Resection (SR) versus Stereotactic Ablative Radiotherapy (SAbR) in High Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC).

Recent Awards & Achievements include

  • 2023 Programme Director, Lampang-Artivion Minimally Invasive Cardiac Surgery Fellowship
  • 2023 Robotic surgery committee member, St John of God
  • 2015-current Evaluation of Cancer Outcomes Barwon South West Steering Committee Member
  • 2018-current Barwon South West Regional Integrated Cancer Service Clinical Advisory Group
  • 2011-22 ANZ Society of Cardiac Thoracic Surgeons Research Committee member
  • 2016-18 Editorial Board, Journal of Thoracic Disease

Feature Publications

  • Matheson LM, Pitson G, Yap CH, Singh M, Collins I, Campbell P, Patrick A, Rogers MJ. Measuring the quality of cancer care in the Barwon South West Region, Victoria, Australia. Int J Qual Health Care. 2021 Feb 20;33(1):mzaa145. doi: 10.1093/intqhc/mzaa145
  • Seitz M, Goldblatt J, Paul E, Marcus T, Larobina M, Yap CH. Minimally Invasive Aortic Valve Replacement Via Right Anterior Mini-Thoracotomy: Propensity Matched Initial Experience. Heart Lung Circ. 2017 Dec 7. pii: S1443-9506(17)31506-8. doi: 10.1016/j.hlc.2017.11.012
  • Dixon B, Smith R, Santamaria JD, Orford NR, Wakefield BJ, Ives K, McKenzie R, Zhang B, Yap CH. A trial of nebulised heparin to limit lung injury following cardiac surgery. Anaesth Intensive Care. 2016; 44(1):28-33.
  • Robertson L, Holdaway D, Yap CH. Retrograde Type A Aortic Dissection Treated with Continuous Perfusion "Branch-First" Aortic Arch Replacement Technique. Heart Lung Circ. 2015; 24(12):e206-9. doi: 10.1016/ j.hlc.2015.07.004.
  • Goh SS, Yap CH. Massive saddle pulmonary embolus. J Card Surg. 2012 Nov;27(6):720

 

How you can help

Participate in a Clinical Trial

To find out about Clinical Trials currently underway at Barwon Health, click here. To learn more about the Adrian Costa Clinical Trials Centre, click here.

Donate

Research requires ongoing investment and there are several ways to support our work. You can make a donation today and contribute to an item on our research group’s wish list, consider a bequest in your will, or establish a lasting legacy fund in your name. No matter what size, your philanthropic support will deliver an immediate impact to this important work. To donate now or for more information, please contact the Barwon Health Foundation.

 

Last Modified: Monday, 18 December 2023

CH_Yap.png

Associate Professor Cheng-Hon Yap

Fellow of the Royal Australasian College of Surgeons, Cardiothoracic Surgery
Masters of Surgery, University of Melbourne
MBBS, University of Melbourne

Cardiothoracic surgeon, Adjunct Senior Research Fellow and Affiliate Associate Professor

Department of Cardiothoracic Surgery

[email protected]

(03) 4215 1969